Speakers: Elizabeth Kelley (Genentech), Karen Samy (Genentech)
Organizers: Cyrus Khojasteh, Genentech; Shichang Miao PhD, Amgen
Date: 2023-06-20
Time: 11:30-13:40 Pacific Time
Registration fee: 0
Location: Online via Zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2023-06-19  (it will close sooner if the seating cap is reached)

About the Topic

[Note: this event is part of the "Success Stories and Lessons Learned from Recent FDA Approvals", a joint series by PBSS and California Life Sciences (CLS). The Zoom link will be provided to the registrants 1+ days before the event]

Seminar Overview: 

In this presentation, the speakers will summarize the 2022 cohort of new drugs approved by the FDA.  Statistics on the overall cohort will be discussed, followed by a short summary of key features of approved drugs. the speakers will highlight case studies with interesting discovery or development stories from the cohort as well as some examples of drugs that have failed to get approvals in 2022 and discuss various reasons and their overall journey.